UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

EClinicalMedicine, 2021-07, Vol.37, p.100962, Article 100962

2021

Volltextzugriff (PDF)

RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

Revista portuguesa de cardiologia, 2024-04, Vol.43 (4), p.219-220

2024

Volltextzugriff (PDF)

Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID‐19

Drug development research, 2020-11, Vol.81 (7), p.768-770

2020

Volltextzugriff (PDF)

Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension

Journal of the American Heart Association, 2022-09, Vol.11 (17), p.e026143-e026143

2022

Volltextzugriff (PDF)

759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia

Pharmacopsychiatry, 2017-01, Vol.50 (1), p.14-18

2017

Volltextzugriff (PDF)

Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

Frontiers in pharmacology, 2021-03, Vol.12, p.603736-603736

2021

Volltextzugriff (PDF)

Involvement of Extracellular Signal-Regulated Kinase 5 in Kinin B1 Receptor Upregulation in Isolated Human Umbilical Veins

The Journal of pharmacology and experimental therapeutics, 2016-04, Vol.357 (1), p.114-124

2016

Volltextzugriff (PDF)

Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19

Pharmacology research & perspectives, 2023-04, Vol.11 (2), p.e01083-n/a

2023

Volltextzugriff (PDF)

Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: An effective bradykinin inactivation pathway

European journal of pharmacology, 2011-09, Vol.667 (1), p.271-277

2011

Volltextzugriff (PDF)

EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin

Thrombosis research, 2012-11, Vol.130 (5), p.746-752

2012

Volltextzugriff (PDF)

Expression and functional evidence of the prostaglandin F2α receptor mediating contraction in human umbilical vein

European journal of pharmacology, 2009-05, Vol.610 (1-3), p.68-74

2009

Volltextzugriff (PDF)

Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects

The Journal of pharmacology and experimental therapeutics, 2007-02, Vol.320 (2), p.713-720

2007

Volltextzugriff (PDF)

Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein

British journal of pharmacology, 2006-03, Vol.147 (5), p.516-523

2006

Volltextzugriff (PDF)

Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F2α on human umbilical vein

European journal of pharmacology, 2004-09, Vol.499 (1-2), p.189-195

2004

Volltextzugriff (PDF)

Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein

British journal of pharmacology, 2003-08, Vol.139 (8), p.1409-1416

2003

Volltextzugriff (PDF)

Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery

The Journal of pharmacology and experimental therapeutics, 2005-06, Vol.313 (3), p.1355

2005

Volltextzugriff (PDF)

Further pharmacological characterization of bradykinin B1 receptor up-regulation in human umbilical vein

The Journal of pharmacology and experimental therapeutics, 1999-09, Vol.290 (3), p.1019

1999

Volltextzugriff (PDF)

Characterization of α 1 ‐adrenoceptor subtypes mediating vasoconstriction in human umbilical vein

British journal of pharmacology, 2009-01, Vol.126 (2), p.437-442

2009

Volltextzugriff (PDF)

Immunopharmacology and Inflammation: The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein

European journal of pharmacology, 2009-01, Vol.602 (1), p.176-179

2009

Volltextzugriff (PDF)

The endocannabinoid anandamide inhibits kinin B 1 receptor sensitization through cannabinoid CB 1 receptor stimulation in human umbilical vein

European journal of pharmacology, 2009, Vol.602 (1), p.176-179

2009

Volltextzugriff (PDF)

Pharmacogenetics in psychiatry: how far are we from clinical application?

Vertex (Buenos Aires, Argentina), 2012-07, Vol.23 (104), p.299

2012

Volltextzugriff (PDF)

Expression and functional evidence of the prostaglandin F 2α receptor mediating contraction in human umbilical vein

European journal of pharmacology, 2009, Vol.610 (1), p.68-74

2009

Volltextzugriff (PDF)

The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein

European journal of pharmacology, 2009-01, Vol.602 (1), p.176-179, Article 176

2009

Volltextzugriff (PDF)

Vasoconstrictor effects of 8-iso-prostaglandin E 2 and 8-iso-prostaglandin F 2α on human umbilical vein

European journal of pharmacology, 2004-09, Vol.499 (1), p.189-195

2004

Volltextzugriff (PDF)

Potentiation of adrenaline vasoconstrictor response by sub-threshold concentrations of U-46619 in human umbilical vein: Involvement of smooth muscle prostanoid TP α receptor isoform

European journal of pharmacology, 2007-05, Vol.562 (3), p.227-235

2007

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAmerican Journal Of Obstetrics And Gynecology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID‐19

Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension

759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia

Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

Involvement of Extracellular Signal-Regulated Kinase 5 in Kinin B1 Receptor Upregulation in Isolated Human Umbilical Veins

Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19

Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: An effective bradykinin inactivation pathway

EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin

Expression and functional evidence of the prostaglandin F2α receptor mediating contraction in human umbilical vein

Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects

Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein

Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F2α on human umbilical vein

Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein

Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery

Further pharmacological characterization of bradykinin B1 receptor up-regulation in human umbilical vein

Characterization of α 1 ‐adrenoceptor subtypes mediating vasoconstriction in human umbilical vein

Immunopharmacology and Inflammation: The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein

The endocannabinoid anandamide inhibits kinin B 1 receptor sensitization through cannabinoid CB 1 receptor stimulation in human umbilical vein

Pharmacogenetics in psychiatry: how far are we from clinical application?

Expression and functional evidence of the prostaglandin F 2α receptor mediating contraction in human umbilical vein

The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein

Vasoconstrictor effects of 8-iso-prostaglandin E 2 and 8-iso-prostaglandin F 2α on human umbilical vein

Potentiation of adrenaline vasoconstrictor response by sub-threshold concentrations of U-46619 in human umbilical vein: Involvement of smooth muscle prostanoid TP α receptor isoform

Aktive Filter

Suchergebnisse filtern